Clinical progression and decision making process in multiple sclerosis

Schumacher GA et al. (1965) Problems of experimental trials of therapy in MS: report by the panel on the evaluation of experimental trials of therapy in MS . Ann NY Acad Sci 122: 552-568 .

Kurtzke JF. (1983) Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS) . Neurology 33: 1444-1452 .

Confavreux C , Aimard G , Devic M. (1980) Course and prognosis of Multiple Sclerosis assessed by the computerized data processing of 349 patients . Brain 103: 281-300 .

Weinshenker BG et al. (1989a) The natural history of multiple sclerosis: a geographically based study. 1. Clinical course and disability . Brain 112: 133-146 .

Weinshenker BG et al. (1989b) The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course . Brain 112: 1419-1428 .

Phadke JG. (1990) Clinical aspects of multiple sclerosis in north-east Scotland with particular reference to its course and prognosis . Brain 113: 1597-1628 .

Runmarker B , Andersen O. (1993) Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up . Brain 116: 117-134 .

Confavreux C , Grimaud J , Vukusic S , Moreau T. (1998) Peut-on prédire l'évolutiondelasclérose en plaques? Rev Neurol (Paris) 154: 624-628 .

Fog T , Linneman F. (1970) The course of multiple sclerosis in 73 cases with computer designed curves . Acta Neurol Scand 46 (suppl. 47): 1-175 .

Poser CM et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols . Ann Neurol 13: 227-231 .

Lee KH et al. (1991) Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: a prospective 2-year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, a CT . Neurology 41: 657-660 .

Martinelli V et al. (1991) Paraclinical tests in acute-onset optic neuritis: basal data and results of a short follow-up . Acta Neurol Scand 84: 231-236 .

Beck RW et al and the Optic Neuritis Study Group . (1993) The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis . N Engl J Med 329: 1764-1769 .

Morrissey SP et al. (1993) The significance of brain magnetic resonance imagining abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study . Brain 116; 135-146 .

Filippi M et al. (1994) Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis . Neurology 44: 635-641 .

Paolino E et al. (1996) A prospective study on the predictive value of CSF oligoclonal bands and MRI in acute isolated neurological syndromes for subsequent progression to multiple sclerosis . J Neurol Neurosurg Psychiat 60: 572-575 .

Barkhof F et al. (1997) Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis . Brain 120: 2059-2069 .

Jacobs LD et al. (1997) Correlation of clinical, magnetic resonance imaging, and cerebrospinal fluid findings in optic neuritis . Ann Neurol 41: 392-398 .

O'Riordan JI et al. (1998) The prognostic value of brain MRI in clinically isolated syndromes of the Central Nervous System: a 10-year follow-up . Brain 121: 495-503 .

Runmarker B , Martinsson T , Wahlström J , Andersen O. (1994) HLA and prognosis in multiple sclerosis . JNeurol 241: 385-390 .

Mumford CJ et al. (1994) The British Isles survey of multiple sclerosis in twins . Neurology 44: 11-15 .

Filippi M et al. (1995) Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: A follow-up study . Neurology 45: 255-260 .

Van Walderveen MAA et al. (1995) Correlating MRI and clinical disease activity in multiple sclerosis: Relevance of hypointense lesions on short-TR/short-TE(T1 weighted) spin-echo images . Neurology 45: 1684-1690 .

Molyneux PD et al. (1998) Correlation between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis . Ann Neurol 43: 332-339 .

Simon JH et al. (1998) Magnetic resonance studies of intramuscular Interferon b-1a for relapsing multiple sclerosis . Ann Neurol 43: 79-87 .

The IFNB Multiple Sclerosis Study Group . (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial . Neurology 43: 655-661 .

Paty DW , Li DKB , the UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group . (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial . Neurology 43: 662-667 .

The IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI analysis Group . (1995) Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial . Neurology 45: 1277-1285 .

Johnson KP et al and the Copolymer 1 Multiple Sclerosis Study Group . (1995) Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind, placebo-controlled trial . Neurology 45: 1268-1276 .

Jacobs L et al. (1996) Intramuscular inferon beta-1a for disease progression in relapsing multiple sclerosis . Ann Neurol 39: 285-294 .

PRISMS (Prevention of relapses and disability by interferon b-1a subcutaneously in multiple sclerosis) Study Group . (1998) Randomised double-blind placebo-controlled study of interferon b-1a in relapsing/remitting multiple sclerosis . Lancet 352: 1498-1504 .

European Study Group on Interferon b-1b in Secondary Progressive MS. (1998) Placebo-controlled multicentre randomised trial of interferon b-1b in treatment of secondary progressive multiple sclerosis . Lancet 352: 1491-1497 .

Bougneres PF et al. (1988) Factors associated with early remission of type I diabetes in children treated with cyclosporine . N Engl J Med 318: 663-670 .